Importance Rare germline genetic variants in several genes are associated with increased
breast cancer (BC) risk, but their precise contributions to different disease subtypes are …

Background Protein truncating variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2 are
associated with increased breast cancer risk, but risks associated with missense variants in …

The high-risk pedigree (HRP) design is an established strategy to discover rare, highly-penetrant,
Mendelian-like causal variants. Its success, however, in complex traits has been …

Background: Previously, family-based designs and high-risk pedigrees have illustrated value
for the discovery of high- and intermediate-risk germline breast cancer susceptibility genes. …

Background We recently showed PAM50 gene expression data can be represented by five
quantitative, orthogonal, multi-gene breast tumor traits. These novel tumor ‘dimensions’ were …

Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched and …

STUDY QUESTION Can we simultaneously assess risk for multiple cancers to identify
familial multicancer patterns in families of azoospermic and severely oligozoospermic men? …

Inherited genetic risk factors play a role in multiple myeloma (MM), yet considerable missing
heritability exists. Rare risk variants at genome-wide association study (GWAS) loci are a …

Background: Relatives of patients with bladder cancer have been shown to be at increased
risk for kidney, lung, thyroid, and cervical cancer after correcting for smoking-related …

Abnormal serum immunoglobulin (Ig) free light chains (FLC) are established biomarkers of
early disease in multiple B-cell lymphoid malignancies, including chronic lymphocytic …